March 28, 2022 11:30 ET | Source: Persistence Market Research Persistence Market Research
New York, New York, UNITED STATES
NEW YORK, March 28, 2022 (GLOBE NEWSWIRE) — As per Persistence Market Research’s latest industry analysis, expanding at a CAGR of 6.2%, the global rosacea therapeutics market is projected to increase from a valuation of US$ 3.94 Bn in 2021 to US$ 7.61 Bn by 2032.
Rosacea is a common skin condition characterized by raised blood vessels and redness on the face, where the nose and cheeks are the most affected areas. The signs and symptoms of rosacea are small red pus-filled bumps that may burst periodically. Around half of the patients experience dry irritated eyes and swollen red eyelids. Other symptoms include an enlarged nose and thickened nasal skin (rhinoplasty). Rosacea mainly affects middle-aged women with fair skin
According to the National Rosacea Association, rosacea affects around 15 million people worldwide. Prevalence of rosacea in the general population is estimated at 2.5% to 5.5%.
Lack of curative treatment for rosacea has resulted in the emphasis on symptomatic treatment to control or eliminate its various signs and symptoms. Growing out-of-pocket expenditure is another driver for the market owing to the rising emphasis on personal health.
Request for sample copy of report: https://www.persistencemarketresearch.com/samples/18793
Key rosacea therapeutic service providers are focusing on market expansion through collaborations and acquisitions. They are promoting their products at professional scientific meetings and conferences. This promotional strategy will be very impactful to penetrate the market. Sales representatives of companies directly contact professionals and physically present their product offerings, thus expanding their company’s presence into different geographies.
An example is, in Feb 2022, Novartis experienced mid-single digit sales growth, margin expansion, and advancement of its robust pipeline.
Key Takeaways from Market Study
Know the methodology of report: https://www.persistencemarketresearch.com/methodology/18793
“Increased prevalence of rosacea and advances in patient-specific pathophysiology will drive the rosacea therapeutics market over the coming years,” says an analyst of Persistence Market Research.
Key providers of rosacea therapeutics are investing in innovating cost-effective treatment to gain the attention of healthcare providers. Along with product innovation, key players are also aiming for various acquisitions to create goodwill and successfully market their products.
Get full access of report: https://www.persistencemarketresearch.com/checkout/18793
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the rosacea therapeutics market in its latest study, presenting historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.
The research study is based on disease type (erythematotelangiectatic rosacea, papulopustular rosacea, ocular rosacea, phymatous rosacea), drug class (antibiotics, immunosuppressants, corticosteroids, others), treatment type (antibiotics [clindamycin, erythromycin/clarithromycin, metronidazole, doxycycline, tetracycline, lymecycline, minocycline], topical treatment [sodium sulfacetamide, azelaic acid, metronidazole, clindamycin, erythromycin, tretinoin, oxymetazoline, isotretinoin tazarotene, adapalene, steroid creams] ,eye drops and lubricants [brimonidine , steroid eye drops, artificial tears ,other eye drops and lubricants, others) other drugs including methotrexate and ivermectin, laser therapy), route of administration (oral, topical, others), distribution channel (institutional sales [hospitals, speciality clinics, academic and research institutes], retail sales [retail pharmacy, drug stores], online sales), and region.
About Persistence Market Research:
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on “micros” by Persistence Market Research helps companies overcome their “macro” business challenges.
Persistence Market Research is always way ahead of its time. In other words, it tables market solutions by stepping into the companies’/clients’ shoes much before they themselves have a sneak pick into the market. The pro-active approach followed by experts at Persistence Market Research helps companies/clients lay their hands on techno-commercial insights beforehand, so that the subsequent course of action could be simplified on their part.
Persistence Market Research
U.S. Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
USA – Canada Toll-Free: 800-961-0353
Visit Our Website: https://www.persistencemarketresearch.com